Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walter

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Neurology|September 30, 2022
Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and CareSeth A Gale, Judith Heidebrink, Joshua Grill, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 2013
Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patientsSarah Walter, Amos Baruch, Jin Dong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2016
Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide)Raju Subramanian, Xiaochun Zhu, Savannah J Kerr, et al.
International Journal of Toxicology|March 5, 2016
Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary HyperparathyroidismMark R Fielden, Charles Dean, Kurt Black, et al.
Neuroscience Letters|April 1, 2006
Polymorphisms in the phosphate and tensin homolog gene are not associated with late-onset Alzheimer's diseaseGillian Hamilton, Farzana Samedi, Jo Knight, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 16, 2022
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S Rafii, Reisa A Sperling, Michael C Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2024
Public and participant involvement as a pathway to inclusive dementia researchSarah Walter, RÍona McArdle, Emily A Largent, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2025
"Being brave, being seen, and having your voice heard": Perspectives of self-advocates and families toward accessible and impactful research of Alzheimer's disease in down syndromeSarah Walter, Lauren Ptomey, Elizabeth Head, et al.
Blood Advances|April 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-upRoger G Owen, Helen McCarthy, Shirley D'Sa, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 4, 2005
Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further studyLynnette J Cook, Luk W Ho, Lin Wang, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Neurology|September 30, 2022
Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and CareSeth A Gale, Judith Heidebrink, Joshua Grill, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 2013
Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patientsSarah Walter, Amos Baruch, Jin Dong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2016
Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide)Raju Subramanian, Xiaochun Zhu, Savannah J Kerr, et al.
International Journal of Toxicology|March 5, 2016
Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary HyperparathyroidismMark R Fielden, Charles Dean, Kurt Black, et al.
Neuroscience Letters|April 1, 2006
Polymorphisms in the phosphate and tensin homolog gene are not associated with late-onset Alzheimer's diseaseGillian Hamilton, Farzana Samedi, Jo Knight, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 16, 2022
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S Rafii, Reisa A Sperling, Michael C Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2024
Public and participant involvement as a pathway to inclusive dementia researchSarah Walter, RÍona McArdle, Emily A Largent, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2025
"Being brave, being seen, and having your voice heard": Perspectives of self-advocates and families toward accessible and impactful research of Alzheimer's disease in down syndromeSarah Walter, Lauren Ptomey, Elizabeth Head, et al.
Blood Advances|April 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-upRoger G Owen, Helen McCarthy, Shirley D'Sa, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 4, 2005
Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further studyLynnette J Cook, Luk W Ho, Lin Wang, et al.
Pageof 6